Neoplasms, Connective and Soft Tissue  >>  perifosine (D21266)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
perifosine (D21266) / AEterna Zentaris
NCT00064324: Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

Completed
2
46
US
perifosine, D21266, octadecylphosphopiperidine, laboratory biomarker analysis, pharmacological study, pharmacological studies
National Cancer Institute (NCI)
Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
11/05
 
NCT00455559: Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Completed
2
40
NA
Perifosine, D-21266, KRX-0401, Imatinib Mesylate, Gleevec, STI-571
AEterna Zentaris, M.D. Anderson Cancer Center
Gastrointestinal Stromal Tumors
11/10
10/11
NCT00401388: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

Completed
2
72
NA
Perifosine, D-21266, KRX-0401, Loperamide, Allopurinol, Antiemetics
AEterna Zentaris, Sarcoma Alliance for Research through Collaboration
Chondrosarcomas, Alveolar Soft Part Sarcomas, Extra Skeletal Myxoid Chondrosarcomas
01/11
10/11

Download Options